Thus, the phenotypes described in klf6−/− mice, stem cells and hepatoma cell lines suggests that endogenous KLF6 is required for cell cycle progression, thereby contrasting with its potential tumor-suppressor activity. This evidence concerns the gene KLF6 and hepatocellular carcinoma.